Literature DB >> 9115753

Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-A.

L A Guay1, J G Sierra-Madero, C K Finegan, E A Rich.   

Abstract

The mechanism of uptake of human immunodeficiency virus-1 (HIV-1) into alveolar macrophages (AM), freshly isolated blood monocytes (MN), and cultured MN (CM) was investigated focusing on the role of CD4 and of surfactant-associated protein A (SP-A). By radioimmunoassay which obviated the problems of auto- and nonspecific fluorescence of more differentiated macrophages, each of the macrophage populations studied expressed CD4. Semiquantitative polymerase chain reaction was performed to assess uptake of HIV-1(JR-FL) into cells. OKT4a (directed against CD4) blocked uptake of HIV-1 into CM, AM, and MN by 67 to 100%. OKT4 (directed against another epitope of CD4) had a smaller and less consistent effect (0-90%), and control antibodies showed minimal effects and only at supersaturating concentrations. SP-A had no effect on uptake of HIV-1 into AM. SP-A also had no consistent effect on production of HIV-1(JR-FL) by AM infected in vitro (p24 antigen ELISA). Thus CD4 is the major receptor for HIV-1 in mononuclear phagocytes, including AM, and SP-A does not modulate entry.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115753     DOI: 10.1165/ajrcmb.16.4.9115753

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  3 in total

1.  Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages.

Authors:  S Worgall; R Connor; R J Kaner; E Fenamore; K Sheridan; R Singh; R G Crystal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 2.  The role of surfactant-associated protein A in pulmonary host defense.

Authors:  V L Shepherd; J P Lopez
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 3.  Abnormalities in host defense associated with HIV infection.

Authors:  James M Beck
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.